Effect of Methylphenidate in ADHD with Epilepsy or with EEG Abnormalities without Seizures
The safety and efficacy of methylphenidate (MPH) in the treatment of ADHD, group 1) with epilepsy and group 2) with EEG abnormalities without seizures, were determined in a study of 119 children (98 males, 21 females; ages 6 to 16 years) at Gazi University, Ankara, Turkey.
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2003-05-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1511 |
Summary: | The safety and efficacy of methylphenidate (MPH) in the treatment of ADHD, group 1) with epilepsy and group 2) with EEG abnormalities without seizures, were determined in a study of 119 children (98 males, 21 females; ages 6 to 16 years) at Gazi University, Ankara, Turkey. |
---|---|
ISSN: | 1043-3155 2166-6482 |